42356 Federal Register / Vol. 70, No.
140 / Friday, July 22, 2005 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5204,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Technology
for DNA Analysis.
Date: August 3, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sally Ann Amero, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7849, Bethesda, MD 20892, (301) 435–
1159, ameros@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurogenesis Special Interest Panel.
Date: August 4, 2005.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Michael A. Lang, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7850, Bethesda, MD 20892, (301) 435–
1265, langm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Genetic
Basis for Psychiatric Diseases.
Date: August 8, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David J. Remondini, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892, (301) 435–
1038, remondid@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pain
Studies.
Date: August 8, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: J. Terrell Hoffeld, PhD,
DDS, Dental Officer, USPHS, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7816, Bethesda, MD 20892, (301) 435–
1781, hoffeldt@csr.nih.gov.
VerDate jul<14>2003 19:28 Jul 21, 2005 Jkt 205001
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Neuronal
Calcium Signaling.
Date: August 11, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Peter B. Guthrie, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Mechanisms of Neurodegeneration.
Date: August 15, 2005.
Time: 4 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Toby Behar, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7850, Bethesda, MD 20892, (301) 435–
4433, behart@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clincial Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 15, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–14494 Filed 7–21–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Use of HIV-Dependent
Expression Constructs and Uses
Therefor for the Development of FDA-
Approvable HIV Diagnostic Kits
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services, is
contemplating the grant of an exclusive
license to practice the invention
embodied in PCT/US04/31967 filed
September 28, 2004 from U.S.
provisional application 60/507,034 (E–
276–2003/0–US–01), entitled ‘‘HIV-
Dependent Expression Constructs and
PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM
Uses Therefor’’ (E–276–2003/0–PCT–
02), (Inventors: Yuntao Wu and Jon
Marsh), to Revix Technology LLC
(hereafter Revix), having a place of
business in Manassas, Virginia. The
patent rights in these inventions have
been assigned to the United States of
America.
DATES: Only written comments and/or
application for a license, which are
received by the NIH Office of
Technology Transfer on or before
September 20, 2005 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Sally Hu, Ph.D., M.B.A., Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, MD 20852–3804;
E-mail: hus@mail.nih.gov; Telephone:
(301) 435–5606; Facsimile: (301) 402–
0220.
SUPPLEMENTARY INFORMATION: E–276–
2003/0–PCT–02 provides nucleic acid
molecules comprising expressible
sequences, which could be reporter or
therapeutic genes, whose expression
depends on the presence of HIV Tat and
Rev proteins. This invention could be
used for detection of HIV infection, in
screening assays to identify compounds
that inhibit HIV infection, and
potentially as a therapeutic to kill HIV-
infected cells and treat HIV-infected
subjects.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 60 days from the date of this
published Notice, NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7.
The field of use may be limited to the
development of FDA-approvable HIV
clinical diagnostic kit.
It has to be noted that the non-
exclusive license opportunities in the
field(s) of use of the development of HIV
detection kit/reagent for research use
and/or cellular screening method for
research use, as well as the exclusive
license opportunity in the field of use of
the development of a novel therapeutic
against HIV infections are still available
for subject invention.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
22JYN1
 Federal Register / Vol. 70, No. 140 / Friday, July 22, 2005 / Notices
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: July 12, 2005.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 05–14502 Filed 7–21–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Federal Emergency
Management Agency, Emergency
Preparedness and Response Directorate,
U.S. Department of Homeland Security.
ACTION: Notice and request for
comments.
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed continuing
information collections. In accordance
FEMA forms
81–93 ..........................................................................................................
Total .....................................................................................................
Estimated Cost: The total cost to
federally-regulated lenders for
completing FEMA Form 81–93 totals
$295,119,000, representing an average
cost of $8.00 per loan transaction
(respondent).
Comments: Written comments are
solicited to (a) evaluate whether the
proposed data collection is necessary for
the proper performance of the agency,
including whether the information shall
have practical utility; (b) evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) enhance the quality, utility, and
clarity of the information to be
collected; and (d) minimize the burden
of the collection of information on those
who are to respond, including through
the use of appropriate automated,
VerDate jul<14>2003 19:28 Jul 21, 2005 Jkt 205001
with the Paperwork Reduction Act of
1995 (44 U.S.C. 3506(c)(2)(A)), this
notice seeks comments concerning
renewal of the Standard Flood Hazard
Determination Form (FEMA Form 81–
93).
SUPPLEMENTARY INFORMATION: FEMA is
seeking to extend the use of the
Standard Flood Hazard Determination
Form, required by Title V, Section 528
of the National Flood Insurance Reform
Act of 1994 (NFIRA). The form records
the determination of whether a structure
is located within an identified Special
Flood Hazard Area and whether flood
insurance is available. Federally-
regulated lender institutions, are
mandated to complete this form for any
loan made, increased, extended,
renewed, or purchased.
Collection of Information
Title: Standard Flood Hazard
Determination Form.
Type of Information Collection:
Extension of a currently approved
collection.
OMB Number: 1660–0040.
Form Numbers: FEMA 81–93
Standard Flood Hazard Determination
Form.
Abstract: On September 23, 1994, the
President signed the Riegle Community
Development and Regulatory
Improvement Act of 1994. Title V of this
Act is the National Flood Insurance
Reform Act (NFIRA). Section 528 of the
No. of re-
spondents
(A)
33,000,000
33,000,000
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses. Comments should be
received within 60 days of the date of
this notice.
ADDRESSES: Interested persons should
submit written comments to Chief,
Records Management Section,
Information Resources Management
Branch, Information Technology
Services Division, Federal Emergency
Management Agency, Emergency
Preparedness and Response Directorate,
Department of Homeland Security, 500
C Street, SW., Room 316, Washington,
DC 20472.
FOR FURTHER INFORMATION CONTACT:
Contact Cecelia Lynch, Program
Specialist, Mitigation Division at (202)
646–7045 for additional information.
PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\22JYN1.SGM
42357
NFIRA requires that FEMA develop a
standard hazard determination form for
recording the determination of whether
a structure is located within an
identified Special Flood Hazard Area
and whether flood insurance is
available. Section 528 of the NFIRA also
requires the use of this form by
regulated lending institutions, Federal
agency lenders, the Federal National
Mortgage Association, the Federal Home
Loan Mortgage Corporation, and the
Government National Mortgage
Association for any loan made,
increased, extended, renewed or
purchased by these entities. The form
developed to comply with the above
requirements is the Standard Flood
Hazard Determination form (FEMA
Form 83–93, dated October 2002). This
form will be completed by federally
regulated lending institutions when
making, increasing, extending, renewing
or purchasing each loan for the purpose
of documenting the factors considered
as to whether flood insurance is
required and available. An estimated
33,000,000 such uses are made each
year. This number is entirely driven by
the volume of mortgage transactions, of
which fluctuations in interest rates is a
principal factor.
Affected Public: Business or other for-
profit, Federal Government.
Estimated Total Annual Burden
Hours: 10,890,000 hours.
Frequency of Burden hours per Annual burden
response response hours
(B) (C) (A x B x C)
1 0.33 (20 minutes) 10,890,000
(1) 0.33 .................... 10,890,000
You may contact the Records
Management Section at (202) 646–3347
or e-mail address: FEMA-Information-
Collections@dhs.gov.
Dated: July 13, 2005.
George S. Trotter,
Acting Branch Chief, Information Resources
Management Branch, Information
Technology Services Division.
[FR Doc. 05–14480 Filed 7–21–05; 8:45 am]
BILLING CODE 9110–11–P
22JYN1